Drugs Online |
 |
 | ||
|
Alphagan Generic Brimonidine Tartrate |
|
| ||
Drugs Online » Prescription Drugs 1 » Alphagan Generic Brimonidine Tartrate Ophthalmic brimonidine is used to lower pressure in the eyes in patients who have glaucoma (high pressure in the eyes that may damage nerves and cause vision loss) and ocular hypertension (pressure in the eyes that is higher than normal but not high enough to cause vision loss). Brimonidine is in a class of drugs called alpha adrenergic agonists. Brimonidine works by decreasing the amount of fluid in the eyes. Buy Alphagan Generic Brimonidine Tartrate and other Prescription Drugs 1 products online at Medstore. Buy Online at Medstore - Click Here!
About Alphagan Generic Brimonidine Tartrate: Product Type: Prescription Drugs 1 Alphagan (Generic Brimonidine Tartrate) Alphagan (Generic Brimonidine Tartrate) Generic Brimonidine Tartrate 2mg/mL 5mL 15mL(3 x 5mL) 30mL(6 x 5mL) Generic Brimonidine Tartrate Alphagan
View more Prescription Drugs 1 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
